Author name: Claritas Rx

In the intricate world of cancer treatment, AvenCell Therapeutics has made waves with its recent achievement. The company successfully raised $112 million in a Series B funding round to further develop its promising CAR-T cell therapies targeting acute myeloid leukemia (AML). This funding is a significant stride toward tackling what many in the industry call “the

The biopharmaceutical industry stands on the brink of a technological revolution. Artificial Intelligence (AI) is poised to transform how drugs are discovered, developed, and delivered. This transformation is not just a future vision; it’s happening now, with significant developments emerging almost weekly. In this blog post, we’ll take a deep dive into the recent advancements

Navigating the complex world of pharmaceutical distribution can be daunting for market access teams and pharmaceutical professionals. At the heart of this complexity lies the buy-and-bill model, a predominant method for distributing provider-administered drugs. This blog post aims to clarify how the buy-and-bill model works, explore its benefits and challenges, and provide insights into emerging

The Federal Reserve’s recent decision to cut interest rates has sent ripples through various industries, but what does it mean for biopharma? Last week, the Fed announced a rate cut by half a percentage point, marking the first reduction since March 2020. This move has been met with a mixture of optimism and caution within

Emerging from stealth mode with a bang, Vironexis Biotherapeutics has announced a successful $26 million seed funding round. This is not just another startup story; it’s a significant development in the realm of cancer gene therapy. For pharmaceutical professionals and biopharma executives, understanding Vironexis’ vision and innovations could provide crucial insights into the future of

In the rapidly evolving landscape of healthcare, patient adherence to treatment plans remains a critical challenge. For patient access teams, predicting which patients are at risk of dropping off their treatment regimens can be the difference between successful outcomes and unmet medical needs. Enter AI predictive analytics—a game changer for enhancing treatment adherence and transforming

Launching a pharmaceutical product can resemble navigating a labyrinth. For market access teams, the stakes are high. Implementing a successful launch strategy requires not just innovation but also strategic precision. This is where benchmarking steps in. By comparing your product’s potential performance against industry standards and competitors, you gain invaluable insights. This blog will walk

Gene therapy holds the promise to revolutionize medicine, particularly for patients with rare and genetic disorders. But how do patient access teams measure success in this complex and emerging field? Key Performance Indicators (KPIs) are essential tools that can guide you through the intricacies of gene therapy treatment, ensuring beneficial outcomes for patients and operational